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INTRODUCTION
A central question in developmental biology is how cells first
acquire polarity and then use that polarity to produce daughter
cells with distinct patterns of gene expression. In C. elegans,
the anteroposterior polarity of the zygote is determined by the
position of the sperm pronucleus (Goldstein and Hird, 1996),
which organizes a cortical and cytoplasmic rearrangement that
leads to the asymmetric distribution of maternally supplied
mRNAs and proteins before first cleavage (reviewed by
Kemphues and Strome, 1997). Two broad classes of maternally
expressed patterning genes have been identified in the C.
elegans embryo: early acting polarity genes, which are required
to establish or maintain embryonic polarity, and cell fate
determinants, which act later to direct lineage-specific patterns
of development (reviewed by Bowerman, 1998). Defects in
polarity genes such as the par genes (partitioning defective)
result in early and extensive polarity defects, including loss of
asymmetry in cell size, cell cycle time, spindle orientation and
distribution of cell fate determinants. Identified cell fate
determinants include transcription factors and transmembrane
receptors that are asymmetrically distributed among early
blastomeres and are required to direct the differentiation of
blastomere-specific cell lineages. 
While it is known that par gene activity is required to
polarize the zygote and enable the proper segregation of
cell fate determinants, the mechanisms of action are poorly
understood. For example, PAR-1 and PAR-4 are cortically
localized serine/threonine kinases; however, none of their
phosphorylation targets is known (Guo and Kemphues, 1995;
Watts et al., 2000). Similarly, par-3 and par-6 encode
conserved PDZ domain proteins that apparently form a protein
complex localized to the anterior cortex (Etemad-Moghadam
et al., 1995; Hung and Kemphues, 1999; Joberty et al., 2000;
Lin et al., 2000). However, the mechanism by which this PAR-
3/PAR-6 complex confers polarity information to downstream
targets is largely unknown. We are interested in understanding
how the PAR proteins direct the asymmetric distribution of
maternally supplied cell fate determinants. 
Considering that maternal factors act to define asymmetries
before zygotic transcription begins, the par-dependent
distribution of maternal gene activities must be regulated by
a variety of post-transcriptional mechanisms, including
differential stability of RNA or protein, asymmetric RNA or
747Development 129, 747-759 (2002)
Printed in Great Britain © The Company of Biologists Limited 2002
DEV8907
The KH domain protein MEX-3 is central to the temporal
and spatial control of PAL-1 expression in the C. elegans
early embryo. PAL-1 is a Caudal-like homeodomain
protein that is required to specify the fate of posterior
blastomeres. While pal-1 mRNA is present throughout the
oocyte and early embryo, PAL-1 protein is expressed only
in posterior blastomeres, starting at the four-cell stage.
To better understand how PAL-1 expression is regulated
temporally and spatially, we have identified MEX-3
interacting proteins (MIPs) and characterized in detail two
that are required for the patterning of PAL-1 expression.
RNA interference of MEX-6, a CCCH zinc-finger protein,
or SPN-4, an RNA recognition motif protein, causes PAL-
1 to be expressed in all four blastomeres starting at the
four-cell stage. Genetic analysis of the interactions between
these mip genes and the par genes, which provide polarity
information in the early embryo, defines convergent genetic
pathways that regulate MEX-3 stability and activity to
control the spatial pattern of PAL-1 expression. These
experiments suggest that par-1 and par-4 affect distinct
processes. par-1 is required for many aspects of embryonic
polarity, including the restriction of MEX-3 and MEX-6
activity to the anterior blastomeres. We find that PAL-1 is
not expressed in par-1 mutants, because MEX-3 and MEX-
6 remain active in the posterior blastomeres. The role of
par-4 is less well understood. Our analysis suggests that
par-4 is required to inactivate MEX-3 at the four-cell stage.
Thus, PAL-1 is not expressed in par-4 mutants because
MEX-3 remains active in all blastomeres. We propose that
MEX-6 and SPN-4 act with MEX-3 to translate the
temporal and spatial information provided by the early
acting par genes into the asymmetric expression of the cell
fate determinant PAL-1.
Key words: Caenorhabditis elegans, Pattern formation, Polarity,
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protein localization, and control of mRNA translation. Based
on the pleiotropy of the par polarity phenotypes, it is likely that
the PAR proteins indirectly regulate the distribution of
maternal determinants through intermediate regulators. One
candidate intermediate regulator is the RNA-binding protein
MEX-3, which regulates the asymmetric expression of
maternally encoded PAL-1 protein (Draper et al., 1996; Hunter
and Kenyon, 1996).
pal-1 encodes a Caudal-like homeodomain protein that is
required to specify the fate of posterior blastomeres (Waring
and Kenyon, 1990; Hunter and Kenyon, 1996). While pal-1
mRNA is present throughout the oocyte and early embryo,
PAL-1 protein is not detected until the four-cell stage and then
is only detected in posterior blastomeres (Hunter and Kenyon,
1996). This temporal and spatial patterning of PAL-1
expression is dependant on MEX-3, which contains two KH
domain RNA binding motifs originally identified in hnRNP K
(Draper et al., 1996; Siomi et al., 1994). mex-3 mutant
hermaphrodites express PAL-1 in oocytes and all cells of
their embryos, resulting in anterior-to-posterior homeotic
transformations that are dependent on pal-1 (Hunter and
Kenyon, 1996). These results suggest that the primary function
of mex-3 in the early embryo is to repress PAL-1 expression.
Indeed, MEX-3 localization is complementary to that of PAL-
1. MEX-3 is present at high levels in mature oocytes, and one-
and two-cell embryos, while at the four-cell stage, MEX-3
becomes enriched in anterior blastomeres relative to posterior
blastomeres (Draper et al., 1996). Proper regulation of PAL-1
expression is also dependent on the pal-1 3¢ UTR, which can
confer mex-3-dependent repression on reporter RNAs (Hunter
and Kenyon, 1996). These observations suggest that MEX-3
may directly repress PAL-1 translation.
Not surprisingly, MEX-3 localization and activity is
dependent on par activity. In par-1, par-4 and par-3 mutant
four-cell embryos, MEX-3 is present at high levels in all cells,
indicating that activity of these par genes is required to restrict
MEX-3 to the anterior (Draper et al., 1996; Bowerman et al.,
1997). In par-1 and par-4 mutants, the presence of MEX-3 in
all cells is coincident with failure to express PAL-1 in any cell,
as would be expected if MEX-3 directly represses PAL-1
expression (Hunter and Kenyon, 1996; Bowerman et al., 1997).
By contrast, four-cell par-3 embryos express PAL-1 in zero,
two or four cells, despite uniformly high levels of MEX-3 in
all cells, indicating that the mere presence of MEX-3 at the
four-cell stage is not sufficient to repress PAL-1 expression
(Bowerman et al., 1997). Finally, par-3 mutant embryos do not
express PAL-1 before the four-cell stage, indicating that par-3
activity is required for spatial but not temporal control of PAL-
1 expression. 
To explore further how MEX-3 translates the cell and
embryonic polarity information provided by the par genes into
the blastomere-specific pattern of PAL-1 expression, we
analyzed par; mex-3 double mutants. Our results suggest that
par activity promotes PAL-1 expression by inhibiting mex-3.
To better understand how mex-3 activity is controlled, we
identified and characterized two MEX-3 interacting proteins,
MEX-6 and SPN-4, which are required to pattern PAL-1
expression. In addition to disrupting the pattern of PAL-1,
inhibition of either gene by RNAi causes a unique terminal
phenotype and has a distinct effect on MEX-3 expression
levels. Investigation of genetic interactions between these
genes and the par genes shows that par-1 and par-3 act
upstream, providing polarity information that controls the
spatial pattern of MEX-3 activity. By contrast, par-4 appears
to act independently of par-1 and par-3 to inactivate MEX-3
at the four-cell stage. We conclude from these analyses that
mex-3, mex-6 and spn-4 integrate spatial and temporal
information from different sources to pattern PAL-1 expression
in the early embryo.
MATERIALS AND METHODS
Nematode strains and alleles
Nematodes were cultured using standard conditions (Brenner, 1974).
The Bristol strain N2 was used as the standard wild-type strain. The
following mutant strains and alleles were also used: DP132,
edIs6[unc119::GFP] IV; EU1, skn-1(zu67) IV/DnT1(IV;V); JJ462,
+/nT1 IV; pos-1(zu148) unc-42(e270)/nT1 V; JJ1237, mex-6(pk440);
JJ1238, unc-30(e191) mex-5(zu199) IV/nT1 (IV;V); JJ1244, mex-
6(pk440); unc-30(e191) mex-5(zu199) IV/nT1 (IV;V); KK184, par-
4(it47ts)V; KK288, rol-4(sc8) par-1(b274)IV/DnT1(IV;V); KK653,
par-3(it71) unc-32(e189)/qC1 dpy-19(e1259ts) glp-1(q339) III;
PD4251, ccIs4251[myo-3::GFP] I; dpy-20(e1282) IV; PD4790,
mIs12[myo-2::GFP] ?; SU93, jcIs1 [jam-1::GFP] IV.
Embryos from homozygous mutant mothers are referred to as
mutant embryos. All listed strains can be obtained from the
Caenorhabditis Genetics Center, with the exception of KK653, which
was kindly provided by Ken Kemphues.
RNAi
Sense and antisense single-stranded RNA was prepared from PCR
products generated with primers that contained T7 and T3 RNA
polymerase promoters and then annealed to produce double-stranded
RNA (dsRNA). Hermaphrodites were injected with dsRNA and
allowed to recover at 25° C for 16 or more hours before progeny were
collected. Progeny from injected hermaphrodites are referred to as
RNAi embryos. mex-3, mex-6 and spn-4 dsRNA was prepared from
full-length cDNAs. par-3 dsRNA was prepared from a PCR product
corresponding to bases 1743-2341 of the 4413 bp par-3-coding
region. At the time embryos were collected for all experiments, 99%
(1539/1553) of mex-6(RNAi) embryos failed to hatch and 100%
(1840/1843) of spn-4(RNAi) embryos failed to hatch.
Yeast two-hybrid screen
The yeast two-hybrid screen was conducted as described by Walhout
and Vidal (Walhout and Vidal, 2001). Bases 10-634 of the 1248 bp
mex-3-coding region, coding for half the protein and containing both
KH domains, was fused to the gal-4 DNA-binding domain (DB) and
used as bait in the screen. All constructs containing the C terminal
half of MEX-3 fused to DB resulted in activation of reporter genes in
the absence of any interacting protein, precluding its use in the screen.
Approximately 200,000 yeast colonies were screened, yielding 14
unique positives. Library inserts were amplified from yeast as
described (Walhout and Vidal, 2001) with the modification that T3
or T7 RNA polymerase sites were added to the ends of the
oligonucleotides.
Inexplicably, injection of K07H8.10 dsRNA produced variable
results from different preparations of RNA from identical templates.
Three different preparations of RNA corresponding to three different
regions of the predicted gene produced an RNAi phenotype
characterized by embryonic lethality and PAL-1 expression in all cells
starting at the four-cell stage. Numerous RNA preparations from the
same templates using the same RNA synthesis protocol failed to
produce embryonic lethality. Attempts to remedy the variability by
using different regions of the RNA were unsuccessful. Because of
these difficulties, we were unable to complete analysis of K07H8.10.
Nancy N. Huang and others
749Parallel pathways pattern PAL-1
We speculate that the variability between RNA preparations may be
due to the extremely repetitive nature of the gene sequence, which
may interfere with the formation of sufficiently long stretches of fully
duplex double-stranded RNA.
Terminal phenotype analysis
Embryos fertilized 16 or more hours after injection were examined
when uninjected control embryos had almost hatched. The following
strains expressing tissue-specific GFP reporters (see nematode strains
and alleles) were used to visualize the indicated tissue types: PD4251
(body wall muscle), SU93 (epidermis), PD4790 (pharyngeal muscle)
and DP132 (neurons). Intestine was visualized by using polarizing
optics to view intestinal cell-specific gut granules. Phenotypes were
confirmed by differential interference contrast (DIC) microscopy of
RNAi embryos from N2 worms. Representative embryos are shown
but some variability in the terminal phenotype of spn-4(RNAi)
embryos was observed. Specifically, spn-4(RNAi) embryos fertilized
at later times after injection generally underwent less differentiation,
most notably often failing to produce differentiated gut tissue.
Antibodies and immunostaining
PAL-1 immunostaining was performed as described (Hunter and
Kenyon, 1996). Affinity purified anti-MEX-3 antibodies were
prepared from the sera of rabbits immunized with full-length MEX-
3::(his)6. Embryos were permeabilized by freeze-cracking and fixed
by immersion in –20° C methanol for 15 minutes, followed by –20 ° C
acetone for 15 minutes. Slides were rinsed in phosphate-buffered
saline with 0.1% Tween (PBSt) before anti-MEX-3 antibodies were
applied (1:100 in 3% bovine serum albumin, Sigma A-9306). Slides
were incubated overnight at 20 ° C and washed three times in PBSt
before secondary antibody (Jackson Immunologicals) was applied. 
MEX-3 intensity measurements
Optical sections of MEX-3-stained embryos were taken 1 m m apart
on the z plane after a 0.4 second exposure using a DeltaVision
microscope CCD camera (Applied Precision) and analyzed using
softWoRx (Applied Precision) software. In no case was the camera
saturated at this exposure setting. The center of each embryo was
defined as the three contiguous sections with the highest Hoescht
33258 signal; all measurements were taken in all three center sections
and then averaged. For each cell analyzed, raw MEX-3 intensity was
measured from a circle of set diameter that contained the entire
nucleus and that was fully enclosed by the cell membrane. A
background measurement was taken a set distance away from the
embryo in an area with no obvious cellular material and then
subtracted from the raw MEX-3 intensity. Importantly, ABa and EMS
lack MEX-3-containing P-granules in both wild-type and spn-4(RNAi)
embryos, ensuring that we are only measuring cytoplasmic MEX-3.
For comparison of ABa to EMS within the same type of embryo,
measurements were taken for both cells from the same embryo. For
comparison of spn-4(RNAi) cells with wild-type cells, an equal
number of spn-4(RNAi) and wild-type embryos were analyzed from
each experiment to minimize the effect of experiment to experiment
variability. The two samples being compared were then subjected to
Welch’s approximate t-test, which is used to compare the means from
two normal populations without assuming equal variances (Zar,
1999).
RESULTS
par-1 and par-4 promote PAL-1 expression by
inhibiting mex-3-mediated repression 
Four previously identified genes, mex-3, par-1, par-4 and par-
3, are required to pattern PAL-1 expression (Hunter and
Kenyon, 1996; Bowerman et al., 1997). To reveal aspects of
the regulatory processes controlled by these proteins, we
scored PAL-1 localization in oocytes and embryos from par;
par and par; mex-3 double mutants that were created by
injecting double-stranded RNA (dsRNA) specific to one gene
into hermaphrodites mutant for a second gene (Fire et al.,
1998). In all cases, injection of gene-specific dsRNA into wild-
type adults produced a phenotype indistinguishable from that
produced by strong loss-of-function alleles (data not shown).
While highly penetrant RNAi and/or strong loss-of-function
alleles were used for all experiments, there is a possibility that
some residual activity remains.
We first examined the genetic relationship between par-1,
par-4 and par-3 with respect to PAL-1 expression. par-3
mutants express PAL-1 in zero, two or four cells at the four-
cell stage, while par-1 and par-4 mutants fail to express PAL-
1 in the early embryo (Fig. 1B-D, Fig. 2A) (Bowerman et al.,
1997). We found that par-3(RNAi) embryos did not express
Fig. 1. PAL-1 immunolocalization in par and
mex-3 single and double mutant embryos.
Strains mutant for the gene indicated above
each column were injected with dsRNA as
indicated to the left of each row (see Fig. 2A
for quantitative summary of staining
experiments). (A) Wild-type four-cell embryos
express PAL-1 in the two posterior
blastomeres. (B) par-3 embryos express PAL-
1 in variable patterns, including in all four
blastomeres, as shown. (C) par-1 and (D) par-
4 embryos do not express PAL-1. (E-H) PAL-
1 is expressed in all blastomeres of all double
mutants that include mex-3(RNAi). We
observed that par-4; mex-3 embryos often
failed to complete early cell cycle events
normally, including nuclear division and
cytokinesis. (I) par-1; par-3(RNAi) embryos
and (J) par-4; par-3(RNAi) embryos do not
express PAL-1. (K) Working model for control of PAL-1 expression. par-3 restricts par-1 and par-4 activities to the posterior, where they
inhibit mex-3 repression of PAL-1. In this and all subsequent figures, embryos are oriented anterior left and dorsal upwards when it is possible
to determine polarity. Scale bar: 10 m m.
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PAL-1 in the absence of par-1 or par-4 (Fig. 1I,J, Fig. 2A),
suggesting that par-3 acts genetically upstream of par-1 and
par-4 for control of PAL-1 expression. This is consistent with
published results showing that anterior PAR-3 protein is
required to restrict PAR-1 protein to the posterior cortex
(Etemad-Moghadam et al., 1995) and may also explain the
variable PAL-1 expression patterns observed in par-3(–)
mutants, as par-1 and par-4 activities may be variably
distributed in par-3 mutant embryos. 
As par-1 and par-4 are required for PAL-1 expression in wild-
type and par-3(–) embryos, we next asked whether par-1 and
par-4 are required for PAL-1 expression in mex-3 mutant
embryos. In par-1; mex-3(RNAi) and par-4; mex-3(RNAi) double
mutants, we found that PAL-1 was expressed at high levels in
oocytes and all blastomeres (Fig. 1G,H, Fig. 2A), suggesting that
par-1 and par-4 normally promote PAL-1 expression by
inhibiting mex-3 activity. par-3; mex-3(RNAi) double mutants
also express PAL-1 in the mex-3(–) pattern instead of in variable
patterns (Fig. 1F, Fig. 2A). Similar results were obtained with
mex-3; par-1 and mex-3; par-3 genetic double mutants (data not
shown). A working model consistent with these results is
presented in Fig. 1K; par-3 is upstream of par-1 and par-4, both
of which are upstream of mex-3. It should be noted that this and
all subsequent models are based on genetic data and are not
intended to indicate direct physical interactions.
Consistent with the proposed model, at the two-cell stage,
PAR-1 is enriched in the posterior blastomere that will give rise
to all PAL-1-expressing cells (Guo and Kemphues, 1995). Two
separate lines of evidence suggest that the spatial pattern of PAL-
1 expression is determined at the two-cell stage. First, PAL-1 is
detected in the posterior of all wild-type four-cell embryos (Fig.
2A), even if the posterior blastomeres have just completed
cytokinesis. This indicates that PAL-1 synthesis begins
immediately after division, suggesting that the regulatory
machinery that promotes PAL-1 expression is in place before
division. Second, four-cell par-3(–) embryos express PAL-1 in
zero, two or four cells, never one or three cells (Fig. 2A)
(Bowerman et al., 1997). The two anterior cells always express
PAL-1 at the same level, and the two posterior cells always
express PAL-1 at the same level. These observations suggest that
the decision to express PAL-1 is made independently in each
blastomere at the two-cell stage, even though the result of this
decision is not evident until the four-cell stage. 
MEX-3 interacting proteins regulate PAL-1 expression 
The spatial pattern of MEX-3 localization correlates with the
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Fig. 2. Quantitative summary of PAL-1 and MEX-3 localization data.
(A) PAL-1 localization patterns in four-cell embryos. Wild-type, par-
1, par-4 or par-3 hermaphrodites, as indicated below the graphs,
were injected with dsRNA, as indicated on the left. PAL-1 was
scored as being present in none of the nuclei, all of the nuclei or
patterned (see key). Patterned embryos express PAL-1 only in
posterior blastomeres (see Fig. 1A), with the exception of par-3(it71)
and par-3(RNAi) embryos, which express PAL-1 in two of four
blastomeres but do not have an obvious polarity. Data for uninjected
par-4(it57ts) and uninjected par-3(it71) embryos are taken from
Bowerman et al. (Bowerman et al., 1997). (B) PAL-1 localization in
embryos at different stages. Genotypes are indicated to the left and
embryo stage is indicated below the graphs. In all cases in which
PAL-1 was scored as patterned, PAL-1 was expressed only in
posterior blastomeres (see Fig. 3B-D). (C) MEX-3 localization in
wild-type and mutant embryos at different stages. Genotypes are
indicated to the left and embryo stage is indicated below the graphs.
In all two- and four-cell embryos in which MEX-3 was scored as
patterned, MEX-3 was clearly brighter in the anterior blastomere(s)
than in the posterior blastomere(s), as in the wild-type four-cell
embryo in Fig. 5A2. In two- and four-cell embryos that were scored
as ‘all’, MEX-3 was detected in all blastomeres with no clear
asymmetries in signal intensity between anterior and posterior. Eight-
cell and 14- to 18-cell embryos were not scored for MEX-3
patterning and were scored only for the presence or absence of
MEX-3 in the majority of blastomeres. In this way, wild-type
embryos expressing MEX-3 in P2 blastomere descendants (see Fig.
5A4) were scored as ‘none’ because they do not express MEX-3 in
the majority of blastomeres. The data presented in these graphs
reflect only the presence or absence of MEX-3 and do not reflect the
intensity of MEX-3 signal, with the exception of clearly ‘patterned’
embryos, as described above. The total number of embryos scored is
indicated above each bar in each case. 
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pattern of PAL-1 repression in wild-type, par-1 and par-4
embryos (Draper et al., 1996; Bowerman et al., 1997).
However, par-3 mutants express PAL-1 in variable patterns at
the four-cell stage, despite uniformly high levels of MEX-3 in
all cells, indicating that MEX-3 is not sufficient to repress
PAL-1 at this stage (Bowerman et al., 1997). To identify
additional proteins that regulate PAL-1 expression, we
conducted a yeast two-hybrid screen with the N-terminal half
of MEX-3 as bait. The screen of 200,000 transformants yielded
14 unique MEX-3 interacting proteins or MIPs (Table 1).
Many of these MIPs contain sequence similarity to factors
implicated in RNA metabolism, consistent with the putative
role of MEX-3 as an RNA-binding protein. We then used RNAi
to determine whether any of the identified MIPs are required
to regulate PAL-1 expression. Depletion of three of the MIPs,
mex-6, ZC404.8 and K07H8.10, caused PAL-1 to be expressed
in all blastomeres starting at the four-cell stage (Fig. 2B, Fig.
3E-L and data not shown), while depletion of the other MIPs
resulted in wild-type or variable PAL-1 expression (Table 1).
K07H8.10 (RNAi) showed inconsistent effects from different
preparations of dsRNA (see Materials and Methods) and was
therefore only minimally analyzed. Our analysis of mex-6 and
ZC404.8 is described in the following sections.
mex-5 and mex-6 are required for spatial, but not
temporal repression of PAL-1
Before being identified as a MIP, mex-6 was characterized
because it shares high sequence identity with mex-5, a maternal
effect lethal gene that causes cell fate transformations leading
to excess muscle when defective (Schubert et al., 2000). mex-
5 and mex-6 encode 70% identical proteins with two CCCH
type zinc fingers, motifs also found in the maternal proteins
PIE-1, MEX-1 and POS-1 (Mello et al., 1996; Guedes and
Priess, 1997; Tabara et al., 1999). Work by Schubert and
colleagues indicates that mex-5 and mex-6 have overlapping
functions; mex-6 single mutants are viable, but mex-5; mex-6
double mutants have a more severe phenotype than mex-5
single mutants. We find that RNAi with full-length mex-6
results in ectopic PAL-1 in anterior cells at high penetrance, a
phenotype not observed in mex-5 or mex-6 single mutants (Fig.
Table 1. MEX-3 two-hybrid screen results
Number of
isolates Gene Similarity Terminal phenotype* PAL-1†
4 mex-3 Two KH domains Embryonic arrest All
1 mex-6 Two CCCH type zinc fingers Embryonic arrest All starting at the four-cell stage
12 spn-4 (ZC404.8) RNA recognition motif Embryonic arrest All starting at the four-cell stage
1 K07H8.10‡ RNA recognition motif Undifferentiated cells All starting at the four-cell stage
2 T04D1.3 GRB2-like SH3 domain Embryonic arrest Variable abnormal
20 pos-1 Two CCCH type zinc fingers Embryonic arrest Variable abnormal
1 B0250.1 Ribosomal protein L8 Undifferentiated cells Variable abnormal
1 F25B4.2 Pellino Embryonic arrest Wild type
2 C17E4.5 RNA recognition motif Undifferentiated cells Wild type
1 C43E11.9 RNA-binding domain Undifferentiated cells Wild type
1 F40F8.5 Novel Viable, fertile n/d
1 K03B4.7 Novel Viable, fertile n/d
1 C27H5.3 RNA recognition motif Viable, fertile n/d
1 E02D9.1 Protein kinase domain Viable, fertile n/d
*Phenotypes of embryos resulting from RNAi (see Materials and Methods). All embryos produced differentiated tissue, except as noted.
†PAL-1 staining in young embryos.
‡K07H8.10(RNAi) showed inconsistent effects from different preparations of dsRNA (see Materials and Methods) and was therefore only minimally analyzed.
n/d, not determined.
Fig. 3. PAL-1 immunolocalization in wild-
type, mex-6(RNAi) and spn-4(RNAi) embryos.
Genotypes and embryo stages are indicated
(see Fig. 2B for quantitative summary of
staining experiments). (A-D) Wild-type
embryos express PAL-1 only in posterior
blastomeres starting at the four-cell stage.
(E-H) mex-6(RNAi) embryos express PAL-1 at
equally high levels in all blastomeres starting
at the four-cell stage. (F) In the four-cell mex-
6(RNAi) embryo shown, the two anterior cells
are dividing before the posterior cells,
demonstrating that mex-6(RNAi) embryos can
maintain asymmetries in cell cycle time
through the four-cell stage. For all 22- to 26-
cell embryos, some nuclei are out of the plane of focus. (I-L) spn-4(RNAi) embryos express PAL-1 in all blastomeres at the four-cell stage;
PAL-1 is often detected at lower levels in anterior blastomeres than posterior blastomeres, as evident in the eight-cell embryo shown (K).
Approximately half of (L) spn-4(RNAi) 22- to 26-cell embryos express PAL-1 in all blastomeres as shown, the remainder express PAL-1 only in
posterior blastomeres, similar to (D) wild-type embryos (see Fig. 2B for quantitation). spn-4(RNAi) embryos characteristically maintain
asymmetries in cell cycle time as evident in the (K) eight-cell embryo shown, where the anterior blastomeres have proceeded to prophase while
the posterior blastomeres are still in interphase. 
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2B; data not shown). These results suggest that injecting full-
length mex-6 dsRNA reduces the function of both mex-5 and
mex-6. Indeed, these genes share extensive regions of
nucleotide identity, including seven regions of 30 nucleotides
or longer with greater than 90% nucleotide identity, conditions
that exceed the minimal requirements for effective gene-
specific RNAi (Parrish et al., 2000). Therefore, we interpret our
results obtained with full-length mex-6 dsRNA as reducing the
function of both mex-5 and mex-6.
mex-6(RNAi) embryos, like mex-3(–) embryos, failed to
undergo morphogenesis and produced excess muscle and
epidermal cells (Fig. 4). However, mex-6(RNAi) embryos also
contained an excess of pharyngeal cells and completely lacked
gut cells, while mex-3 mutant embryos produce a reduced
number of pharyngeal cells and a normal amount of gut. Like
mex-6(RNAi) embryos, the genetic mex-5(zu199) mutant
produces an excess of pharyngeal cells. Curiously, the mex-
6(pk440); mex-5(zu199) double mutant produces fewer
pharyngeal cells (Schubert et al., 2000). These results indicate
that mex-6(RNAi) may only partially inhibit mex-5 and that
residual mex-5 or mex-6 activity may promote pharyngeal
development. With the exception of pharynx production, the
mex-6(RNAi) phenotype appears to be identical to the mex-
6(pk440); mex-5(zu199) double mutant phenotype (data not
shown).
mex-5 and mex-6 were previously shown to be required for
the posterior localization of a number of maternal proteins,
including PAL-1 (Schubert et al., 2000). To determine whether
mex-5 and mex-6 are required for the temporal control of PAL-
1 expression, like mex-3, or the spatial control of PAL-1
expression, like par-3, we stained mex-6(RNAi) embryos for
PAL-1. We found that mex-6(RNAi) disrupts spatial but not
temporal control of PAL-1 expression, resulting in embryos
that show strong PAL-1 expression in all nuclei starting at the
four-cell stage (Fig. 2B, Fig. 3E-H). The ectopic PAL-1
expression in mex-6(RNAi) embryos is consistent with the
excess muscle and excess epidermis observed, which are fates
promoted by the homeodomain protein PAL-1.
spn-4 is required for spatial, but not temporal
repression of PAL-1
ZC404.8 encodes an RNA recognition motif (RRM) protein
that was also identified as a mutant with defects in spindle
rotation, spn-4, and as a POS-1 interacting protein, pip-1
(Gomes et al., 2001) (K. Ogura and Y. Kohara, personal
communication). pos-1, which was also identified in our two-
hybrid screen with MEX-3, encodes a germline-restricted
protein containing two CCCH zinc-finger motifs also found in
mex-5 and mex-6 (Tabara et al., 1999). spn-4(RNAi) produced
mex-3-like embryos that failed to undergo morphogenesis,
produced excess muscle, excess epidermal cells, a reduced
number of pharyngeal cells and a normal amount of intestine
(Fig. 4) (at later times after injection, an increasing proportion
of animals fail to differentiate intestine and other tissues – see
Materials and Methods). 
Starting at the four-cell stage, spn-4(RNAi) embryos
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Fig. 4. Terminal phenotypes and cell
type abundance in mip(RNAi) embryos.
The DIC micrographs in the top row
show that mex-3, mex-6 and spn-4 RNAi
embryos produce differentiated cell
types but do not undergo
morphogenesis. In the remaining rows,
body wall muscle, epidermis, intestine,
pharynx and neurons were visualized as
described in Materials and Methods.
mex-3, mex-6 and spn-4 RNAi embryos
produce excess body wall muscle and
epidermal cells. mex-3 and spn-4 RNAi
embryos produce a normal amount of
intestine but reduced pharynx, while
mex-6(RNAi) embryos produce no
intestine and excess pharynx. By the
time the neural GFP marker was
expressed, neural tissue was dispersed
throughout the embryo, making it
difficult to judge the amount of neural
tissue. Thus, we conclude only that
neural tissue is present in mex-3, mex-6
and spn-4 RNAi embryos and do not
make any conclusions about the relative
amount. For all embryos, some
fluorescent signal is out of the plane of
focus. This is most noticeable in the
intestine micrographs, where the wild-
type intestine has elongated but the mex-
3 and spn-4 RNAi intestine has not. 
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consistently showed weak ectopic PAL-1 expression in anterior
cells in addition to wild-type PAL-1 expression in the posterior
(Fig. 2B, Fig. 3I-L). (See Fig. 3K to compare weak versus
strong staining in an eight-cell embryo.) This indicates that
spn-4, like mex-5 and mex-6 and par-3, is required for spatial,
but not temporal patterning of PAL-1. The ectopic PAL-1
expression in spn-4(RNAi) embryos is consistent with the mex-
3-like terminal phenotype.
mex-5, mex-6 and spn-4 have opposite effects on
MEX-3 expression levels
To determine whether mex-5, mex-6 and spn-4 affect MEX-3
expression or activity, we stained mex-6(RNAi) and spn-
4(RNAi) embryos with MEX-3 antibodies. In mex-6(RNAi)
oocytes and newly fertilized one-cell embryos, MEX-3 was
distributed throughout the cell at levels similar to wild type
(Fig. 2C and data not shown). However, by the four-cell stage,
MEX-3 levels in all blastomeres were lower than is typically
seen in wild-type posterior blastomeres (Fig. 5A2,B2).
Furthermore, MEX-3 was undetectable by the eight-cell stage,
while it is readily detectable throughout wild-type eight-cell
embryos (Fig. 2C, Fig. 5A3,B3). These results suggest that the
anteriorly localized MEX-5 and MEX-6 proteins (Schubert et
al., 2000) (N. N. H. and C. P. H., unpublished) are required to
stabilize MEX-3 in the anterior to pattern its expression. If
MEX-3 is required at the four-cell stage to repress PAL-1
expression, the ectopic PAL-1 in mex-6(RNAi) embryos can be
explained solely by the failure to stabilize MEX-3, although
we cannot rule out the possibility that mex-5 and mex-6 may
be directly involved in PAL-1 repression. 
By contrast, in young spn-4(RNAi) embryos, MEX-3 protein
levels appeared higher in all blastomeres than is ever detected
in wild type, and in most cases was not clearly patterned (Fig.
2C, Fig. 5C). This indicates that MEX-3 is either not active or
is insufficient at the four-cell stage to repress PAL-1 expression
in spn-4(RNAi) embryos. Furthermore, we found that MEX-3
staining persisted much longer than in wild type. In 14- to 18-
cell wild-type embryos, MEX-3 is undetectable except for
weak staining in the P2 blastomere descendants (Fig. 5A4),
whereas in spn-4(RNAi) embryos, MEX-3 is readily detectable
at the 14- to 18-cell stage and in some cases even persists
through the 20- to 30-cell stage (Fig. 2C, Fig. 5C4 and data not
shown). These results suggest that spn-4 is required to inhibit
MEX-3 accumulation in older embryos. 
To determine whether the presence of MEX-3 at the 14- to
18-cell stage actually reflects an overabundance of MEX-3 at
the four-cell stage, when PAL-1 expression is perturbed, we
used image analysis software to measure the intensity of MEX-
3 staining in wild-type and spn-4(RNAi) four-cell embryos
(Fig. 6A-C). We measured MEX-3 intensity in the anterior
blastomere ABa, which normally expresses high levels of
MEX-3, and in the posterior blastomere EMS, which normally
expresses low levels of MEX-3. In wild-type embryos, we
found that ABa was always brighter than EMS (Fig. 6A),
reflecting the qualitative differences observed by eye. By
contrast, much smaller differences were found in spn-4(RNAi)
embryos between ABa and EMS, demonstrating that spn-4 is
required to pattern MEX-3 (Fig. 6B). 
To determine whether MEX-3 levels were higher in spn-
4(RNAi) embryos than in wild type, we compared the measured
levels between embryos. Although there is considerable
variation in the antibody staining, a statistically significant
difference was observed between spn-4(RNAi) and wild-type
ABa blastomeres (Fig. 6C), indicating that spn-4(RNAi)
embryos do contain an overabundance of MEX-3 at the four-
cell stage. The largest difference was observed between
spn-4(RNAi) and wild-type EMS blastomeres (Fig. 6C),
underscoring both the lack of patterning in spn-4(RNAi)
embryos and the higher overall levels of MEX-3 in spn-
4(RNAi) embryos. These observations strongly suggest that
spn-4 acts to limit MEX-3 levels and that its activity is
preferentially targeted to the posterior blastomeres of four-cell
embryos. 
These quantitative measurements reflect what we
qualitatively observe at the four-cell stage. Furthermore, these
data suggest that the persistence of MEX-3 at the 14- to 18-
cell stage in spn-4(RNAi) embryos does reflect an
overabundance of MEX-3 at the four-cell stage. Because of the
difficulty in making these measurements, and the relatively
large sample sizes required to obtain statistically significant
comparisons, all remaining samples were assayed solely for the
presence or absence of MEX-3 at the 8- and 14- to 18-cell
stages. For all genotypes, the persistence of MEX-3 appeared
to correlate with the staining intensity in young embryos.
mex-5 and mex-6 prevent spn-4-dependent
degradation of MEX-3
Although mex-5, mex-6 and spn-4 are required to repress PAL-
1 expression in anterior blastomeres, they have opposite effects
on MEX-3 expression levels. To determine whether mex-5 and
mex-6 are required for the abnormal accumulation of MEX-3
observed in spn-4(RNAi) embryos, or whether spn-4 is required
for the abnormally low levels of MEX-3 observed in mex-
6(RNAi) embryos, we stained mex-6(RNAi); spn-4(RNAi)
double mutant embryos for MEX-3. In the double mutants,
MEX-3 persisted through the 14- to 18-cell stage, as in spn-
4(RNAi) embryos (Fig. 2C, Fig. 5D), suggesting that anterior
mex-5 and mex-6 (Schubert et al., 2000) (N. N. H. and C. P.
H., unpublished) normally act to restrict spn-4-dependent
degradation of MEX-3 to the posterior. As an indication that
the mex-6 dsRNA was active in these co-injection experiments,
MEX-3-stained P-granules were distributed throughout the
double mutant embryos as in mex-6(RNAi) embryos (see Fig.
5D2). 
Despite the persistent MEX-3 staining observed in spn-
4(RNAi) embryos, PAL-1 is expressed at high levels in the
posterior blastomeres and at low levels in the anterior
blastomeres. To determine whether mex-5 and mex-6 are
required for this anterior-posterior asymmetry in PAL-1
expression, we stained mex-6(RNAi); spn-4(RNAi) double
mutant embryos for PAL-1. In these double mutants, PAL-1
was expressed strongly in all blastomeres (Fig. 2B and data
not shown), suggesting that mex-5 and mex-6 partially inhibit
PAL-1 expression in the anterior of spn-4(RNAi) embryos.
Consistent with this interpretation, we found that MEX-5 was
localized normally to the anterior of two-cell and four-cell spn-
4(RNAi) embryos (data not shown). 
From these results we are able to place mex-5, mex-6
and spn-4 into a working model for regulation of PAL-1
expression (Fig. 6D). spn-4 acts to promote MEX-3
degradation while mex-5 and mex-6 normally act in the
anterior to stabilize MEX-3 and allow it to repress PAL-1.





embryo stages are indicated
(see Fig. 2C for quantitative
summary of staining
experiments). (A) In wild-
type embryos, MEX-3 is
present through the eight-
cell stage and essentially
disappears by the 14- to 18-
cell stage, except for weak




undetectable by the eight-
cell stage. (C,D) In spn-
4(RNAi) embryos and mex-
6(RNAi); spn-4(RNAi)
embryos, MEX-3 persists
through to the 14- to 18-cell
stage. (E) In par-1 embryos,
MEX-3 persists through the
eight-cell stage but is
undetectable by the 14- to
18-cell stage. (F,G) Defects
in par-1 do not effect the
MEX-3 phenotype of mex-
6(RNAi) embryos or spn-
4(RNAi) embryos. (H) In
par-4 embryos, MEX-3
persists through the eight-
cell stage but is
undetectable by the 14- to
18-cell stage. (I) par-4 is
required for the premature
degradation of MEX-3 seen
in mex-6(RNAi) embryos.




in the intensity of MEX-3
signal in the micrographs
are often the result of the
embryo position in the focal
plane, and may not reflect
actual asymmetries in
protein distribution. Only
clear asymmetries that are
visible in all focal planes, as
in A2, were scored as
patterned (see Fig. 2C).
Representative embryos are
shown. Owing to the high intensity of the signal, (C,D,G,J) spn-4(RNAi) two- and four-cell embryos are generally underexposed relative to
other embryos. All eight-cell embryos are shown at the same exposure, with the exception of C3 and G3, which are underexposed relative to the
other eight-cell embryos. All 14- to 18-cell embryos are shown at the same exposure with the exception of C4, G4 and J4, which are
underexposed relative to the other 14- to 18-cell embryos. In two-cell (B1) mex-6(RNAi) and (C1) spn-4(RNAi) embryos, the anterior cell is
typically larger than the posterior cell as in (A1) wild type, demonstrating that mex-6 and spn-4 RNAi embryos can maintain asymmetries in
cell size. mex-6(RNAi) disrupts P-granule localization as monitored by MEX-3 localization to P-granules (Draper et al., 1996). Ten out of 10
mex-6(RNAi) embryos mis-segregate P-granules to all blastomeres of the four-cell embryo, while 10/10 of spn-4(RNAi) embryos segregate
P-granules normally. (D) mex-6(RNAi); spn-4(RNAi) double mutant embryos show persistent MEX-3 expression characteristic of spn-4(RNAi)
embryos, while 8/10 four-cell embryos mislocalize P-granules like mex-6(RNAi) embryos, indicating that both injected dsRNAs were effective
in RNAi.
755Parallel pathways pattern PAL-1
Based on the observation that MEX-3 is present but inactive
in par-3 and spn-4(RNAi) embryos, we suggest that mex-3
exists in active and inactive forms. The active form is normally
associated with mex-5 and mex-6 and is competent to repress
PAL-1 while the inactive form is normally targeted for
degradation by spn-4. In the absence of spn-4, we propose that
inactive MEX-3 accumulates and interferes with active MEX-
3, resulting in the weak ectopic PAL-1 expression seen in spn-
4(RNAi) embryos.
par-3 and par-1 act upstream of mex-5, mex-6 and
spn-4
To determine how mex-5, mex-6 and spn-4 interact with the
par genes that are known to affect PAL-1 expression, we
immunostained mip; par double mutants for PAL-1. par-3
embryos express PAL-1 in variable patterns starting at the
four-cell stage, while par-1 and par-4 embryos fail to express
PAL-1 at all in the early embryo (Fig. 2A, Fig. 7A-C). By
contrast, mex-6(RNAi) and spn-4(RNAi) embryos express
PAL-1 in all cells at the four-cell stage (Fig. 2A, Fig. 3F,J).
We found that PAL-1 was expressed in all mip; par-3 and mip;
par-1 double mutants (Fig. 2A, Fig. 7D,E,G,H), suggesting
that par-3 and par-1 function upstream of mex-5, mex-6 and
spn-4 to regulate PAL-1 expression. This is consistent with
published results showing that par-1 is required to localize
MEX-5 to the anterior while PAR-1 and PAR-3 are localized
normally in mex-5(–); mex-6(–) embryos (Schubert et al.,
2000) and the results indicating that par-3 is upstream of par-
1. Furthermore, the characteristic par-3 cell arrangement
(evident in Fig. 7A,D) was often (9/10) suppressed by spn-
4(RNAi) in par-3; spn-4(RNAi) embryos (Fig. 7G), again
consistent with spn-4 acting downstream of par-3. Two-cell
par-3( - ) embryos characteristically divide with both spindles
oriented anteroposteriorly (Cheng et al., 1995), while two-cell
spn-4 embryos characteristically divide with both spindles
oriented dorsoventrally (Gomes et al., 2001).
MEX-3 localization in mip; par-1 embryos is also consistent
with par-1 acting upstream of mex-5, mex-6 and spn-4. par-1
is not required for the premature degradation of MEX-3 seen
in mex-6(RNAi) embryos (Fig. 2C, Fig. 5F) or for the excess
accumulation of MEX-3 seen in spn-4(RNAi) embryos (Fig.
2C, Fig. 5G). This suggests that mex-5, mex-6 and spn-4 work
downstream of or parallel to par-1 with respect to MEX-3
localization. These data allow us to integrate par-1, par-3, mex-
Fig. 6. MEX-3 intensity and working model. MEX-3
intensity in ABa and EMS from individual (A) wild-type
or (B) spn-4(RNAi) embryos. The average ratio between
ABa and EMS intensities is given. (C) Comparison of
MEX-3 intensity in wild-type and spn-4(RNAi)
blastomeres. Units are arbitrary for MEX-3 intensity.
(D) Working model for regulation of PAL-1 expression. MEX-3 exists in active and inactive (*) forms. The active form is normally associated
with mex-5 and mex-6 and is competent to repress PAL-1. In the absence of mex-5 and mex-6, the inactive form is targeted for degradation by
spn-4. In the absence of spn-4, the inactive MEX-3 accumulates and interferes with active MEX-3.
Cell Mean –  s.d. (n) Ratio t-test
spn-4(RNAi)  ABa
wild-type ABa
1101 –  443 (8)
645 –  220 (8) 1.7 P < 0.05
spn-4(RNAi)  EMS
wild-type EMS
985 –  331 (8)
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5, mes-6 and spn-4 into one working model for the regulation
of PAL-1 expression (Fig. 8B). Anteriorly localized par-3
restricts par-1 to the posterior. Posterior par-1 then restricts
mex-5 and mex-6 to the anterior, where they stabilize MEX-3
and allow it to repress PAL-1 expression in the anterior. In the
absence of mex-5 and mex-6 in the posterior, MEX-3 is
degraded through a spn-4-dependent process. 
par-4 analysis indicates that spn-4 acts in a separate
pathway from mex-5 and mex-6 to pattern PAL-1
We found that par-4 activity is not required for PAL-1
expression in mex-6(RNAi) embryos (Fig. 2A, Fig. 7F), but
par-4 is required for PAL-1 expression in spn-4(RNAi)
embryos (Fig. 2A, Fig. 7I), suggesting that spn-4 acts in a
separate pathway from mex-5 and mex-6 to control PAL-1
expression. We next looked at MEX-3 expression in mip: par-
4 double mutant embryos. We found that par-4 is not required
for the abnormal persistence of MEX-3 seen in spn-4(RNAi)
embryos (Fig. 2C, Fig. 5J), but par-4 is required for the
premature degradation of MEX-3 seen in mex-6(RNAi)
embryos (Fig. 2C, Fig. 5I). We showed earlier that this
premature degradation is also dependent on spn-4 activity,
indicating that par-4 and spn-4 are both required for MEX-3
degradation in mex-6(RNAi) embryos. Furthermore, par-4 is
required for PAL-1 expression in spn-4(RNAi) embryos (Fig.
2A, Fig. 7I), suggesting that par-4 inactivates MEX-3 or a
MEX-3 co-factor. We suggest in our working model in Fig. 8B
that par-4 is required to inactivate MEX-3 and target it for spn-
4-dependent degradation. 
spn-4 is required to restrict skn-1 expression and
function
spn-4(RNAi) embryos differ from both mex-3(–) and mex-
6(RNAi) embryos in an important respect; in a large
proportion of spn-4(RNAi) embryos, PAL-1 expression
regresses towards a wild-type pattern. This is particularly
evident at the 22- to 26-cell stage when zygotic pal-1
transcription is thought to begin (Fig. 2B). In wild-type 22-
to 26-cell embryos, PAL-1 expression begins to decrease in
the EMS descendants relative to the P2 descendants (Hunter
and Kenyon, 1996). In homozygous pal-1 null embryos from
heterozygous mothers, PAL-1 expression in the P2
descendants begins decreasing at this time as well, indicating
that the continued high expression of PAL-1 in the P2
descendants requires zygotic pal-1 transcription (Edgar et al.,
2001; Hunter and Kenyon, 1996). 
Interestingly, PAL-1 zygotic expression appears to require
pal-1 function. The transcription factor SKN-1 inhibits pal-1
function in the EMS lineage (Bowerman et al., 1993; Hunter
and Kenyon, 1996). In 22- to 26-cell skn-1 mutants, PAL-1
levels remain high in the EMS descendants (C. P. H.,
unpublished). Thus, the observation that half the spn-4(RNAi)
embryos expressed PAL-1 in wild-type patterns at the time of
maternal to zygotic transition in PAL-1 expression suggests
that the ectopic PAL-1 may not be active in half the embryos.
Nancy N. Huang and others
Fig. 7. PAL-1 immunolocalization in par; mip(RNAi) double
mutant embryos. Strains mutant for the gene indicated above each
column were injected with dsRNA (left) (see Fig. 2A for
quantitative summary of staining experiments). (A) par-3 mutants
express PAL-1 in variable patterns, including in all four
blastomeres, as shown. (B,C) par-1 and par-4 mutants do not
express PAL-1. (D-F) All double mutants that include mex-
6(RNAi) express PAL-1 at a high level in all four blastomeres.
(G,H) par-3; spn-4(RNAi) embryos and par-1; spn-4(RNAi)
embryos express PAL-1 in all four blastomeres. The characteristic
par-3 cell arrangement (evident in A,D) was suppressed by spn-
4(RNAi) in 9/10 (G) par-3; spn-4(RNAi) embryos. (I) par-4; spn-
4(RNAi) embryos do not express PAL-1. We observed that par-4; spn-4(RNAi) embryos, like par-4; mex-3(RNAi) embryos (see Fig. 1), often
failed to complete early cell cycle events normally, including nuclear division and cytokinesis.
Fig. 8. Summary and
proposed model.
(A) Summary of PAL-1
(red) and MEX-3 (green)
localization data.





1(orange) to the posterior.
par-1 then restricts MEX-5
and MEX-6 (purple) to the
anterior. mex-5 and mex-6
protect MEX-3 from
degradation in the anterior,
enabling the continued
repression of PAL-1. In the absence of mex-5 and mex-6 in the
posterior, par-4 inactivates MEX-3 (*), and subjects it to rapid spn-4-
dependent degradation. In the absence of spn-4, inactive MEX-3 can
interfere with active MEX-3, resulting in ectopic PAL-1 expression.
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One possibility is that SKN-1 may be anteriorly expressed in
some spn-4(RNAi) embryos and may inhibit the activation of
zygotic pal-1 expression. To test this, we first stained spn-
4(RNAi) embryos for SKN-1. We found four-cell embryos that
expressed SKN-1 predominantly in the two posterior
blastomeres, as in wild type (Bowerman et al., 1993), as well
as embryos that expressed SKN-1 strongly in all four
blastomeres (data not shown). If this anterior SKN-1 can
inhibit zygotic PAL-1 expression, then PAL-1 should continue
to be expressed in the anterior blastomeres of all skn-1; spn-
4(RNAi) embryos. Therefore, we injected skn-1 mutant
hermaphrodites with spn-4 dsRNA and found that, as
predicted, all double mutant embryos continued to express
PAL-1 in anterior blastomeres through the 22- to 26-cell stage
(Fig. 2B). These experiments show that spn-4 is required to
pattern SKN-1 localization and that ectopic SKN-1 inhibits at
least some pal-1 functions.
DISCUSSION
We have identified two proteins, MEX-6 and SPN-4, which are
required to pattern PAL-1 expression at the four-cell stage. Our
characterization of their genetic interactions with the other
factors known to affect PAL-1 patterning, mex-3, par-1, par-4
and par-3, suggests that these two genes couple the spatial and
temporal information provided by the par genes to the spatial
and temporal pattern of gene expression. Previous work has
shown that mex-3 is required to repress PAL-1 expression and
that MEX-3 localization in oocytes and early embryos
correlates with the temporal and spatial pattern of PAL-1
repression (Hunter and Kenyon, 1996; Draper et al., 1996).
Although the striking correlation between MEX-3 localization
and PAL-1 repression is suggestive, in some mutants PAL-1 is
expressed in blastomeres that contain high levels of MEX-3
(Bowerman et al., 1997), indicating that MEX-3 activity is
regulated independently of expression levels. 
Our analysis of par; mex-3(RNAi) double mutants suggests
that the patterned expression of PAL-1 at the four-cell stage
requires PAL-1 repression in oocytes and in one- and two-cell
embryos. If PAL-1 is expressed in the oocyte, as it is in mex-
3 mutants, all blastomeres will inherit PAL-1 protein and
translationally active pal-1 RNA, thereby disrupting the spatial
regulation of PAL-1 expression. Furthermore, analysis of par;
par-3(RNAi) double mutants indicates that both par-1 and par-
4 are required to promote PAL-1 expression at the four-cell
stage when mex-3-dependent repression is intact. These results
also show that par-3 mutations do not disrupt the regulatory
interactions that pattern PAL-1, just their spatial distributions
in two-cell embryos. To clarify these interactions and to gain
further understanding of how cell polarity information can
produce asymmetric patterns of gene expression, we sought to
identify additional genes required to pattern PAL-1 expression.
As MEX-3 is necessary but insufficient to repress PAL-1
expression, we used a two-hybrid screen to identify MEX-3
interacting proteins and then used RNAi to characterize their
functions. By these methods we identified two proteins, SPN-
4 and MEX-6, which produced a consistent and informative
RNAi phenotype suitable for detailed investigations. 
Previous analysis of mex-5 and mex-6 indicates that these
homologous proteins function redundantly and act downstream
of par-1 to control the asymmetric expression and/or activity
of a variety of factors important for early embryogenesis
(Schubert et al., 2000). Among these, PAL-1 is the only one
for which a specific regulator has been identified, namely
MEX-3. We found that mex-5 and mex-6 are required for the
continued expression of MEX-3 in early embryos and also for
continued repression of PAL-1 in anterior blastomeres at the
four-cell stage. For both these phenotypes, mex-6(RNAi) is
epistatic to par-1(–), consistent with the requirement for par-
1 in localizing MEX-5 to the anterior blastomere of two-cell
embryos (Schubert et al., 2000). Thus, it appears that MEX-5
and MEX-6 act as adapters to transmit the polarity information
conferred by the par genes into the control of PAL-1
expression. As MEX-6 was identified as a MEX-3 interacting
protein, one possibility is that MEX-5 and MEX-6 act as co-
repressors with MEX-3 at the four-cell stage. Indeed, all
double mutants that included mex-6(RNAi) express PAL-1 in
all blastomeres of four-cell embryos whether MEX-3 is present
or not (summarized in Fig. 8A). 
A direct interaction between MEX-3 and anteriorly-
localized MEX-5 and MEX-6 may also provide a mechanism
for maintaining MEX-3 levels in anterior blastomeres. A
physical interaction between MEX-5, MEX-6 and MEX-3, or
some modification resulting from a physical interaction, could
protect MEX-3 from protein degradation. Nevertheless, MEX-
5 and MEX-6 are not absolutely required for MEX-3 stability,
as MEX-3 is stable in par-4(–) and spn-4(RNAi) embryos,
whether or not mex-5 and mex-6 are active. This suggests that
par-4(+) and spn-4(+) may be required to destabilize MEX-3. 
In all genetic backgrounds tested, reducing the function of
par-4 or spn-4 resulted in elevated MEX-3 levels in the
posterior, indicating that par-4 and spn-4 may normally be
required to reduce MEX-3 levels in the posterior. Because
PAR-4 and SPN-4 are localized to all cells of two- and four-
cell embryos (Watts et al., 2000) (K. Ogura and Y. Kohara,
personal communication; N. N. H. and C. P. H., unpublished),
their activity must be asymmetrically controlled in the anterior
and posterior blastomeres. This difference could be attributed
to MEX-5 and MEX-6, which are localized to the anterior and
may act to protect MEX-3 from par-4- and spn-4-dependent
degradation. 
Despite these similarities, par-4 and spn-4 have different
effects on PAL-1 expression. In spn-4(RNAi) embryos, weak
ectopic PAL-1 was detected in anterior blastomeres and normal
levels of PAL-1 were detected in posterior blastomeres.
Therefore, the abnormally abundant MEX-3 in spn-4(RNAi)
embryos is either not active or insufficient to repress PAL-1
expression. However, this PAL-1 expression is completely
dependent on par-4 activity. Thus, as in wild-type and par-3(–)
embryos, par-4 activity is required to promote PAL-1
expression in spn-4(RNAi) embryos. One hypothesis consistent
with all the data is that par-4 activity directly or indirectly
inactivates MEX-3. The observation that par-1 and par-4
mutations have different effects on PAL-1 expression in spn-
4(RNAi) embryos provides evidence that par-1 and par-4 act
by distinct mechanisms to pattern PAL-1 expression at the
four-cell stage.
Because PAL-1 expression is dependent on both par-1
and par-4, one attractive hypothesis is that one of these
serine/threonine kinases (PAR-1) spatially restricts PAL-1
derepression to the posterior, and the other (PAR-4) temporally
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derepresses PAL-1 expression after the two-cell stage. At the
two-cell stage, cortically localized PAR-1 is restricted to the
posterior blastomere that will give rise to all the PAL-1-
expressing cells (Guo and Kemphues, 1995). By contrast,
PAR-4 is uniformly localized to both blastomeres at the two-
cell stage, suggesting it may be active in temporal regulation
(Watts et al., 2000). par-4 is unique among the par genes in
that it is not asymmetrically localized and does not affect
asymmetry of the first cleavage (Kemphues et al., 1988),
suggesting that it may act later than par-1 and par-3, perhaps
providing a temporal cue for early embryonic events including
PAL-1 derepression. In this scenario, all blastomeres in four-
cell par-1 mutant embryos execute the fate of anterior
blastomeres that do not derepress PAL-1, and all blastomeres
in four-cell par-4 mutant embryos maintain the state of
younger blastomeres that do not yet express PAL-1. As par-3
activity is required for PAR-1 localization (Etemad-Moghadam
et al., 1995), par-3 mutants may variably distribute par-1
activity, resulting in the variable PAL-1 expression patterns that
are observed.
Precedence for separable temporal and spatial control of
post-transcriptional gene regulation in C. elegans is provided
by the analysis of GLP-1 (Evans et al., 1994). glp-1 mRNA is
present throughout the oocyte and early embryo, while GLP-1
protein is expressed only in anterior blastomeres from the two-
to 28-cell stage. cis regulatory elements have been mapped to
two distinct regions in the glp-1 3¢ UTR, with one region being
required for temporal control and the other for spatial
patterning. As the pal-1 3¢ UTR can confer a PAL-1-like
expression pattern on reporter RNAs (Hunter and Kenyon,
1996), PAL-1 expression may be regulated by RNA-binding
proteins such as MEX-3 and the MIPs bound to the 3 ¢ UTR. In
turn, temporal and spatial activity of MEX-3 and the MIPs
would ultimately be controlled by the par genes.
These complex genetic interactions are synthesized into a
formal genetic model in Fig. 8B in which separate temporal
and spatial control pathways converge on MEX-3 to control its
activity and stability at the four-cell stage. First, we propose
that par-3 and par-1 function in a simple linear pathway
to localize MEX-5 and MEX-6 to the anterior (Etemad-
Moghadam et al., 1995; Schubert et al., 2000) (N. N. H. and
C. P. H., unpublished), where they function to stabilize and/or
activate MEX-3. This stabilization probably involves direct
contact as we identified MEX-6 as a MIP. In addition to
stabilizing MEX-3, mex-5 and mex-6 are required at the four-
cell stage for the continued repression of PAL-1. This is
demonstrated by the par-4; mex-6(RNAi) and mex-6(RNAi);
spn-4(RNAi) embryos, which express PAL-1 at high levels in
all blastomeres despite abundant MEX-3. 
Temporal control of PAL-1 expression may be provided by
par-4(+) activity. We propose that par-4 acts directly or
indirectly to inactivate MEX-3-dependent repression of PAL-
1 at the two- to four-cell stage. The inactivated MEX-3 is then
subject to rapid spn-4-dependent degradation. mex-5 and mex-
6 activity in the anterior protects MEX-3 from inactivation and
subsequent degradation, thus restricting PAL-1 expression to
the posterior. To explain the weak PAL-1 expression in the
anterior of spn-4(RNAi) embryos, we propose that inactive
MEX-3 interferes with active MEX-3. The identification of
MEX-3 as a MEX-3 interacting protein (Table 1) is consistent
with MEX-3 forming an oligomer. However, we must
emphasize that the interactions between MEX-3 and the MIPs
were identified in yeast and may not reflect physical
interactions in the C. elegans embryo.
As par-4 encodes a serine/threonine kinase, it is tempting
to speculate that it may inactivate MEX-3 by directly
phosphorylating it. Phosphorylation of KH domain proteins
has been shown to affect their RNA binding activity (Wang et
al., 1995). Furthermore, phosphorylation is often used to target
proteins for degradation (for a review, see Jackson et al., 2000).
Finally, MEX-3 is hyperphosphorylated and rapidly degraded
in wild-type early embryos (C. P. H., unpublished). 
As MEX-3, MEX-5, MEX-6 and SPN-4 all contain RNA-
binding motifs, an appealing hypothesis is that these proteins
interact on the pal-1 3 ¢ UTR. However, mex-3 is the only
factor that appears to be specific for regulation of PAL-1
expression; mex-5 and mex-6 are required to segregate several
unrelated gene products, and spn-4 is required to control
spindle orientation and SKN-1 localization (Draper et al.,
1996; Hunter and Kenyon, 1996; Schubert et al., 2000;
Gomes et al., 2001) (our data). This raises the possibility of
combinatorial control, where MEX-5, MEX-6 and SPN-4
may each act on numerous RNA targets to control their
expression, perhaps by regulating the activity and stability of
other message-specific trans-acting factors similar to MEX-
3. The concept of combinatorial control is well documented
in transcriptional control, where individual transcription
factors can act as activators or repressors of transcription
depending on the other factors that are bound (for a review,
see Roberts, 2000). Combinatorial control is also emerging
as a dominant theme in translational control, but few specific
examples are well understood (for a review, see Gray and
Wickens, 1998).
Asymmetric protein expression resulting from post-
transcriptional regulation is best understood in Drosophila.
However, Drosophila embryos are distinct from nematode and
vertebrate embryos because they are polarized before
fertilization and begin development as a syncytial blastoderm.
This means that maternal RNAs and proteins can be localized
during oocyte maturation and that after fertilization, RNA and
protein can diffuse freely through the cytoplasm. Perhaps
because of these unique characteristics, many factors important
for converting polarity cues to asymmetric gene expression
during early Drosophila development do not have homologs in
other systems; two notable exceptions being Caudal/PAL-1
(Macdonald and Struhl, 1986; Waring and Kenyon, 1991) and
Par-1 (Guo and Kemphues, 1995; Shulman et al., 2000). In the
C. elegans embryo, many asymmetrically expressed proteins
have been identified, but relatively little is known about how
that asymmetric expression is achieved (for a review, see
Goodwin and Evans, 1997). The new findings presented in this
work provide a framework for understanding how initial
cellular polarity can be refined to produce asymmetric gene
expression in a cellular system. 
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